AI-generated summary
The authors report a multicenter randomized trial in which children aged 8 to 13 with myopia received repeated low-level red-light therapy plus single-vision spectacles or spectacles alone. Over 12 months, the red-light group showed less axial elongation and less refractive progression than the control group. No severe adverse events or functional or structural damage were observed.
- Participants
- 264
- Who or what was studied
- Children aged 8 to 13 years with myopia (cycloplegic spherical equivalent -1.00 to -5.00 D)
- Wavelengths
- 650 nm
- Limits stated in the abstract
- The abstract does not describe blinding beyond single-blind design or long-term follow-up beyond 12 months.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 0.29 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Myopia, Repeated low-level red light, Randomized controlled trial, Confidence interval, Primary outcome, Control group, Wavelength, Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.